This study aims to determine the diagnostic and therapeutic potential of miR-183-5p in bladder carcinomas by targeting TPM1 gene, through estimating the miR-183-5p expression profiles in urine cytology and their corresponding BC biopsies, with subsequent TPM1 protein expression evaluation in urinary bladder biopsies. This evidence concerns the gene TPM1 and urinary bladder carcinoma.